Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Birrer

Showing results (71-80 of 222) with videos related to

Pageof 23
Sort By:
Oncogene|October 14, 2021
A highly annotated database of genes associated with platinum resistance in cancerDongqing Huang, Sara R Savage, Anna P Calinawan, et al.
Journal of Medicinal Chemistry|February 6, 2004
Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cellsShengquan Liu, Chad W Brown, K Darrell Berlin, et al.
Neoplasia (New York, N.Y.)|June 2, 2009
Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cellsJoseph Kwong, Franky Leung Chan, Kwong-kwok Wong, et al.
The Oncologist|January 31, 2023
Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian CancerRichard T Penson, Allison J Ambrosio, Christin A Whalen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analysesHiroshi Tsuda, Yoichi M Ito, Yasuo Ohashi, et al.
Cancer|June 22, 2010
Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancerChristina M Annunziata, Helene Tuft Stavnes, Lilach Kleinberg, et al.
Cancer Research|April 19, 2005
RRP22 is a farnesylated, nucleolar, Ras-related protein with tumor suppressor potentialCandice Elam, Luke Hesson, Michele D Vos, et al.
Molecular Cancer Therapeutics|December 16, 2020
Neutralization of TGFβ Improves Tumor Immunity and Reduces Tumor Progression in Ovarian CarcinomaBrandon M Roane, Selene Meza-Perez, Ashwini A Katre, et al.
International Journal of Cancer|January 1, 2009
The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferationPauline J van der Watt, Christopher P Maske, Denver T Hendricks, et al.
Targeted Oncology|October 29, 2015
Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced CancerJohn Sarantopoulos, Monica M Mita, Michael J Birrer, et al.
Pageof 23

Showing results (71-80 of 222) with videos related to

Sort By:
Pageof 23
Oncogene|October 14, 2021
A highly annotated database of genes associated with platinum resistance in cancerDongqing Huang, Sara R Savage, Anna P Calinawan, et al.
Journal of Medicinal Chemistry|February 6, 2004
Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cellsShengquan Liu, Chad W Brown, K Darrell Berlin, et al.
Neoplasia (New York, N.Y.)|June 2, 2009
Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cellsJoseph Kwong, Franky Leung Chan, Kwong-kwok Wong, et al.
The Oncologist|January 31, 2023
Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian CancerRichard T Penson, Allison J Ambrosio, Christin A Whalen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analysesHiroshi Tsuda, Yoichi M Ito, Yasuo Ohashi, et al.
Cancer|June 22, 2010
Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancerChristina M Annunziata, Helene Tuft Stavnes, Lilach Kleinberg, et al.
Cancer Research|April 19, 2005
RRP22 is a farnesylated, nucleolar, Ras-related protein with tumor suppressor potentialCandice Elam, Luke Hesson, Michele D Vos, et al.
Molecular Cancer Therapeutics|December 16, 2020
Neutralization of TGFβ Improves Tumor Immunity and Reduces Tumor Progression in Ovarian CarcinomaBrandon M Roane, Selene Meza-Perez, Ashwini A Katre, et al.
International Journal of Cancer|January 1, 2009
The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferationPauline J van der Watt, Christopher P Maske, Denver T Hendricks, et al.
Targeted Oncology|October 29, 2015
Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced CancerJohn Sarantopoulos, Monica M Mita, Michael J Birrer, et al.
Pageof 23